Open AccessIrsogladine maleate and rabeprazole in non-erosive reflux disease: A double-blind, placebo-controlled study
Author(s) -
Takayoshi Suzuki,
Masashi Matsushima,
Aya Masui,
Shingo Tsuda,
Jin Imai,
Jun Nakamura,
Yoko Tsukune,
Teiji Uchida,
Hiroki Yuhara,
Muneki Igarashi,
Jun Koike,
Tetsuya Mine
Publication year - 2015
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v21.i16.5023
Subject(s) - nerd , rabeprazole , medicine , gastroenterology , proton pump inhibitor , placebo , reflux , omeprazole , randomized controlled trial , gerd , disease , pathology , alternative medicine
To evaluate the efficacy of adding irsogladine maleate (IM) to proton-pump inhibitor (PPI) therapy in non-erosive reflux disease (NERD) treatment.